Trial Profile
Oral Mucosal Absorption Study of ICI176,334-1 (Bicalutamide New Formulation) in Japanese Healthy Male Subjects
Status:
Discontinued
Phase of Trial:
Phase I
Latest Information Update: 19 Oct 2015
Price :
$35
*
At a glance
- Drugs Bicalutamide (Primary)
- Indications Prostate cancer
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 17 Aug 2011 New trial record